Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects

American Journal of Clinical Nutrition

Volumn 84, Issue 3, 2006, Pages 497-504

  Lichtenstein, Alice H ^a   Matthan, Nirupa R ^a   Jalbert, Susan M ^a   Resteghini, Nancy A ^a   Schaefer, Ernst J ^a   Ausman, Lynne M ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

C reactive protein; Cardiovascular disease; CVD risk factors; Fatty acids; Genetic modification; HDL cholesterol; LDL cholesterol; Selective breeding; Soybean oils; trans fatty acids; Triacylglycerol

Indexed keywords

C REACTIVE PROTEIN; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LINOLENIC ACID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLEIC ACID; SATURATED FATTY ACID; SOYBEAN OIL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN; APOLIPOPROTEIN B; LIPOPROTEIN A; TRANS FATTY ACID;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; OXIDATION; PHOSPHOLIPID BLOOD LEVEL; RISK FACTOR; BLOOD; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DIET THERAPY; DRUG EFFECT; GENETICS; HYDROGENATION; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TRANSGENIC PLANT;

GLYCINE MAX;

APOLIPOPROTEINS; APOLIPOPROTEINS B; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; FATTY ACIDS; FEMALE; HUMANS; HYDROGENATION; HYPERLIPIDEMIAS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PLANTS, GENETICALLY MODIFIED; RISK FACTORS; SOYBEAN OIL; TRANS FATTY ACIDS; TRIGLYCERIDES;

EID: 33750104302     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/84.3.497     Document Type: Article

References (37)

1. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
2. Krauss RM, Eckel RH, Howard B, et al. AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000;102:2284-99.
3. Kris-Etherton PM, Yu S. Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr 1997;65:1628-44S.
4. Clarke R, Frost C, Collins R, Appleby P, Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997;314:112-7.
5. Hazebroek JP. Analysis of genetically modified oils. Prog Lipid Res. 2000;39:477-506.
6. Broun P, Gettner S, Somerville C. Genetic engineering of plant lipids. Annu Rev Nutr 1999;19:197-216.
7. Broun P, Somerville C. Progress in plant metabolic engineering. Proc Natl Acad Sci U S A 2001;98:8925-7.
8. Hegsted DM. Serum-cholesterol response to dietary cholesterol: a reevaluation. Am J Clin Nutr 1986;44:299-305.
9. Keys A, Anderson JT, Grande F. Serum cholesterol response to change in the diet. Metabolism 1965;14:747-58.
10. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992;12:911-9.
11. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982;28:1379-88.
12. Nguyen TWG. Improved methods for separation of total HDL and subclasses. Clin Chem 1989;35:1086-94.
13. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509.
14. Agren JJ, Julkunen A, Penttila I. Rapid separation of serum lipids for fatty acid analysis by a single aminopropyl column. J Lipid Res 1992;33:1871-6.
15. King JM, White PJ. Impact of processing on formation of trans fatty acids. Adv in Exp Med Biol 1999;459:51-65.
16. Flickinger BD, Huth PJ. Dietary fats and oils: technologies for improving cardiovascular health. Curr Atheroscl Rep 2004;6:468-76.
17. Gunstone FD. Movements towards tailor-made fats. Prog Lipid Res 1998;37:277-305.
18. Willis WM, Lencki RW, Marangoni AG. Lipid modification strategies in the production of nutritionally functional fats and oils. Crit Rev Food Sci Nutr. 1998;38:639-74.
19. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 1990;323:439-45.
20. Lichtenstein AH, Ausman LA, Jalbert SM, Schaefer EJ. Comparison of different forms of hydrogenated fats on serum lipid levels in moderately hypercholesterolemic female and male subjects. N Engl J Med 1999;340:1933-40.
21. Kromhout D, Menotti A, Bloemberg B, et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 1995;24:308-15.
22. Ascherio A, Katan MB, Zock PL, Stampfer MJ, Willett WC. Trans fatty acids and coronary heart disease. N Engl J Med 1999;340:1994-8.
23. Imming P, Germershaus O. Products of the determination of the iodine value with iodine monobromide. Archiv der Pharmazie 2002;335:449-51.
24. Sanchez-Muniz FJ, Bastida S. Frying oil discarding: polar content vs oligomer content determinations. Forum Nutr 2003;56:345-7.
25. Fuller G, Kohler GO, Applewhite TH. High oleic acid safflower oil: a new stable edible oil. J Am Oil Chem Soc 1966;43:477-8.
26. Wardlaw GM, Snook JT. Effect of diets high in butter, corn oil, or high-oleic acid sunflower oil on serum lipids and apolipoproteins in men. Am J Clin Nutr 1990;51:815-21.
27. Lu Z, Hendrich S, Shen N, White PJ, Cook LR. Low linolenate and commercial soybean oils diminish serum HDL cholesterol in young free-living adult females. J Am Coll Nutr 1997;16:562-9.
28. Allman-Farinelli MA, Gomes K, Javaloro J, Petocz P. A diet rich in high-oleic-acid sunflower oil favorably alters low-density lipoprotein cholesterol, triglycerides and factor VII coagulant activity. J Am Diet Assoc 2005;105:1071-9.
29. Lichtenstein AH, Ausman LM, Carrasco W, Jenner JL, Ordovas JM, Schaefer EJ. Hydrogenation impairs the hypolipidemic effect of corn oil in humans. Hydrogenation, trans fatty acids, and plasma lipids. Arterioscler Thromb 1993;13:154-161.
30. Matthan NR, Welty FK, Barrett PH, et al. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol 2004;24:1092-7.
31. Madsen T, Skou HA, Hansen VE, et al. C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol 2001;88:1139-42.
32. Mezzano D, Leighton F, Martinez C, et al. Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors. Eur J Clin Nutr 2001;55:444-51.
33. Burdge G. Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care 2004;7:137-44.
34. Oomen CM, Ocke MC, Feskens EJ, Kok FJ, Kromhout D. α-Linolenic acid intake is not beneficially associated with 10-y risk of coronary artery disease incidence: the Zutphen Elderly Study. Am J Clin Nutr 2001;74:457-63.
35. Ulbricht C, Basch E, Axentsev S, et al. Omega-3 fatty acids, fish oil, alpha-linolenic acid. J Am Nutraceutical Assoc 2003;6:2-18.
36. Wang C, Chung M, Balk E, et al. n-3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006;84:5-17.
37. Wijendran V, Hayes KC. Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr 2004;24:597-615.